Presented by: Jacqueline Carville

Originally aired:  May 11, 2016

ImmunoChemistry Technologies offers multiple tools for fluorescent imaging in the context of cancer research and oncology. ICT’s in vitro cell-based apoptosis assays allow biomedical researchers to investigate biological systems and the effects of disease and treatment. In this presentation, learn how to quantify caspase activity in vitro, monitor caspases and cathepsins, measure mitochondrial membrane potential, quantify necrosis and apoptosis, and detect serine protease activity. Ultimately, these various assay kits enable cancer researchers to evaluate drug treatment, monitor side-effects, and calculate dose-response.